Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany

Author： Berger K. Hessel F. Kreuzer J. Smala A. Diener H.C.

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.24, Iss.1, 2008-01, pp. : 267-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness of clopidogrel in STEMI patients in the Netherlands: a model based on the CLARITY trial

By Thurston S.J. Heeg B. de Charro F. van Hout B.

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 641-651

Informa Healthcare

Access to resources Recommend Favorite

Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany

By Brüggenjürgen B. Lindgren P. Ehlken B. Rupprecht H.-J. Willich S.

The European Journal of Health Economics, Vol. 8, Iss. 1, 2007-03 ,pp. : 51-57

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of rosuvastatin versus ezetimibe/simvastatin in managing dyslipidemic patients in Mexico

By Briseño Germán Gómez Mino-León Dolores

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1075-1081

Informa Healthcare

Access to resources Recommend Favorite

The Cost-Effectiveness of Losartan versus Captopril in Patients with Symptomatic Heart Failure

Cardiology, Vol. 91, Iss. 3, 1999-09 ,pp. : 189-194

Karger

Access to resources Recommend Favorite

Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trials*

By Berg Jenny Fidan Dogan Lindgren Peter

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 2089-2101

Informa Healthcare

Access to resources Recommend Favorite